Evaluation of Postmenopausal Bleeding: Combining Transvaginal Ultrasound with Endometrial Biopsy

SUMMARY:

Postmenopausal uterine bleeding requires prompt evaluation. Transvaginal ultrasonography remains an important diagnostic tool in this clinical scenario. However, in most patients, it should no longer be used as a first line approach. Rather, transvaginal ultrasound should be combined with endometrial tissue sampling as part of the initial evaluation.

Endometrial Thickness

• Measure the maximum anterior–posterior thickness on a long-axis transvaginal view
• Transvaginal ultrasonography should not be used as the sole modality for triage in most patients with postmenopausal bleeding
• Thin endometrial echo
  • Defined as ≤4 mm
  • Endometrial fluid should not be included in the measurement
  • The negative predictive value of a ≤4 mm cutoff is lower than previously reported, particularly in populations at increased risk for high‑grade endometrial cancer
• A thin endometrium does not exclude all pathology, including high‑grade subtypes (e.g., serous, clear cell)

Interpretation

• Thickened endometrium is not diagnostic of a specific pathology
• Ultrasound measurement of endometrial thickness alone is insufficient to exclude malignancy in patients with postmenopausal bleeding

Recommended Management

• In most patients with postmenopausal bleeding, initial evaluation should include both transvaginal ultrasonography and endometrial tissue sampling
• Ultrasound‑only triage may be considered only in select patients meeting all of the following conditions
  • Single episode of postmenopausal bleeding
  • Fully visualized endometrium ≤4 mm
  • No risk factors strongly associated with endometrial cancer
  • Reliable access to prompt follow‑up care
• Proceed to endometrial sampling if abnormal endometrium is observed on transvaginal ultrasound
• Endometrial sampling should be included upfront when
  • Clinical presentation is suspicious
  • Risk factors for endometrial cancer are present, including:
    • Obesity (BMI >30)
    • Exogenous or unopposed estrogen use
    • SERM use (eg, tamoxifen)
    • Nulliparity
    • Diabetes mellitus
    • Genetic predisposition (eg, Lynch syndrome)
    • Black race, recognizing race as a social construct associated with higher incidence of aggressive histologic subtypes
• Outpatient endometrial sampling using a disposable device remains the preferred initial histologic method

Persistent or Recurrent Bleeding

• Any continued or recurrent postmenopausal bleeding warrants histologic evaluation regardless of endometrial thickness
• Proceed to hysteroscopy with dilation and curettage if bleeding persists and blind sampling is negative

KEY POINTS:

• If transvaginal ultrasound images are technically inadequate, proceed with
  • Sonohysterography
  • Office hysteroscopy
  • Endometrial sampling
• If insufficient tissue is obtained on endometrial sampling
  • Transvaginal ultrasound may be used to assist further evaluation
  • If bleeding has ceased and criteria for deferred biopsy are met, close clinical follow‑up is acceptable
• Persistent or recurrent bleeding always requires histologic evaluation, including in patients with a thin endometrial echo

Postmenopausal Patients Without Bleeding

• Transvaginal ultrasound should not be used as a screening tool for endometrial cancer
• Incidentally noted endometrial thickness >4 mm should be interpreted in clinical context and individualized based on patient risk factors

Learn More – Primary Sources:  

ACOG Clinical Practice Update: Updated Guidance Regarding The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Individuals With Postmenopausal Bleeding